ROBIN HART: Open Payments
NPI 1750334728 · CUMBERLAND, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 15 payments from 6 companies in 2025. Trend: 2023 $24 · 2024 $51 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $108 |
| Exact Sciences Corporation | 3 | $56 |
| Lilly USA, LLC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| ABBVIE INC. | 1 | $24 |
| INOGEN, INC. | 1 | $23 |
Products named: TRELEGY ELLIPTA, Cologuard Collection Kit, MOUNJARO, VRAYLAR, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH, FARXIGA, AIRSUPRA.
Industry payments across RI — which companies pay providers there.
